Madrigal Pharmaceuticals SG&A Expense (Quarterly) Insights

Madrigal Pharmaceuticals Inc (MDGL)

193.31 -11.34 (-5.54%) USD | NASDAQ | Apr 25, 11:15

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2005. Upgrade now.

Date	Value
December 31, 2023	46.54M
September 30, 2023	27.58M
June 30, 2023	17.84M
March 31, 2023	16.18M
December 31, 2022	14.56M
September 30, 2022	12.14M
June 30, 2022	11.77M
March 31, 2022	9.658M
December 31, 2021	11.71M
September 30, 2021	8.287M
June 30, 2021	10.11M
March 31, 2021	7.209M
December 31, 2020	6.126M
September 30, 2020	5.494M
June 30, 2020	5.639M
March 31, 2020	4.605M
December 31, 2019	5.044M
September 30, 2019	4.748M
June 30, 2019	7.11M
March 31, 2019	5.746M
December 31, 2018	5.583M
September 30, 2018	5.122M
June 30, 2018	2.717M
March 31, 2018	1.871M
December 31, 2017	2.399M

Date	Value
September 30, 2017	1.955M
June 30, 2017	1.623M
March 31, 2017	1.695M
December 31, 2016	2.232M
September 30, 2016	6.285M
June 30, 2016	0.551M
March 31, 2016	0.222M
December 31, 2015	0.1451M
September 30, 2015	0.1974M
June 30, 2015	3.127M
March 31, 2015	4.15M
December 31, 2014	4.241M
September 30, 2014	3.241M
June 30, 2014	2.94M
March 31, 2014	5.324M
December 31, 2013	3.463M
September 30, 2013	4.171M
June 30, 2013	4.187M
March 31, 2013	3.878M
December 31, 2012	3.352M
September 30, 2012	2.796M
June 30, 2012	2.882M
March 31, 2012	2.646M
December 31, 2011	2.803M
September 30, 2011	3.131M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

4.605M

Minimum

Mar 2020

46.54M

Maximum

Dec 2023

12.23M

Average

9.658M

Median

Mar 2022

SG&A Expense (Quarterly) Benchmarks